# Entrada Therapeutics, Inc.: filings

TRDA · Nasdaq · CIK 1689375 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/trda.md) · [Financials](/companies/trda/financials.md) · [Filings](/companies/trda/filings.md) · [Insiders](/companies/trda/insiders.md)

## Reports and events: 86 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 215, 144 69, 8-K 51, 3 20, 10-Q 15, CORRESP 7, DEFA14A 7, S-8 7, SC 13G/A 7, 4/A 6, SC 13G 6, SCHEDULE 13G/A 6, UPLOAD 6, 10-K 5, DEF 14A 5, ARS 4, D 3, EFFECT 3, SC 13D 3, 424B5 2, S-3 2, SCHEDULE 13D/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 10-K/A 1, 10-Q/A 1, 144/A 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, D/A 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 11:52 ET | [8-K](/filings/0001689375-26-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-26-000057 |
| 2026-09-10 | 20:26 ET | [SCHEDULE 13D/A](/filings/0001231919-26-001160.md) | Ownership report, active investor, amended | 0001231919-26-001160 |
| 2026-08-05 | 11:11 ET | [10-Q](/filings/0001689375-26-000054.md) | Quarterly report, period 2026-06-30 | 0001689375-26-000054 |
| 2026-08-05 | 11:04 ET | [8-K](/filings/0001689375-26-000052.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-26-000052 |
| 2026-06-10 | 20:06 ET | [8-K](/filings/0001104659-26-072326.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-072326 |
| 2026-05-19 | 22:32 ET | [8-K](/filings/0001104659-26-063325.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-063325 |
| 2026-05-07 | 11:14 ET | [10-Q](/filings/0001689375-26-000028.md) | Quarterly report, period 2026-03-31 | 0001689375-26-000028 |
| 2026-05-07 | 11:11 ET | [8-K](/filings/0001689375-26-000027.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689375-26-000027 |
| 2026-04-24 | 12:30 ET | [DEF 14A](/filings/0001689375-26-000021.md) | Proxy statement, period 2026-06-10 | 0001689375-26-000021 |
| 2026-02-26 | 12:09 ET | [10-K](/filings/0001689375-26-000011.md) | Annual report, period 2025-12-31 | 0001689375-26-000011 |
| 2026-02-26 | 12:04 ET | [8-K](/filings/0001689375-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-26-000009 |
| 2026-01-08 | 12:25 ET | [8-K](/filings/0001689375-26-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events | 0001689375-26-000003 |
| 2025-11-18 | 21:38 ET | [SCHEDULE 13D/A](/filings/0001674324-25-000005.md) | Ownership report, active investor, amended | 0001674324-25-000005 |
| 2025-11-06 | 12:06 ET | [10-Q](/filings/0001689375-25-000050.md) | Quarterly report, period 2025-09-30 | 0001689375-25-000050 |
| 2025-11-06 | 12:02 ET | [8-K](/filings/0001689375-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000049 |
| 2025-08-06 | 11:10 ET | [10-Q](/filings/0001689375-25-000043.md) | Quarterly report, period 2025-06-30 | 0001689375-25-000043 |
| 2025-08-06 | 11:06 ET | [8-K](/filings/0001689375-25-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000041 |
| 2025-06-11 | 20:08 ET | [8-K](/filings/0001104659-25-058536.md) | 5.07 Shareholder vote results | 0001104659-25-058536 |
| 2025-06-03 | 11:05 ET | [8-K](/filings/0001689375-25-000027.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001689375-25-000027 |
| 2025-05-08 | 11:09 ET | [10-Q](/filings/0001689375-25-000024.md) | Quarterly report, period 2025-03-31 | 0001689375-25-000024 |
| 2025-05-08 | 11:03 ET | [8-K](/filings/0001689375-25-000022.md) | 2.02 Results of operations | 0001689375-25-000022 |
| 2025-04-29 | 20:05 ET | [8-K](/filings/0001104659-25-041204.md) | 2.05 Exit or disposal costs | 0001104659-25-041204 |
| 2025-04-25 | 11:00 ET | [DEF 14A](/filings/0001104659-25-039000.md) | Proxy statement, period 2025-06-11 | 0001104659-25-039000 |
| 2025-03-24 | 11:06 ET | [8-K](/filings/0001689375-25-000018.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000018 |
| 2025-02-27 | 12:07 ET | [10-K](/filings/0001689375-25-000011.md) | Annual report, period 2024-12-31 | 0001689375-25-000011 |
| 2025-02-27 | 12:02 ET | [8-K](/filings/0001689375-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-25-000009 |
| 2025-02-24 | 12:02 ET | [8-K](/filings/0001689375-25-000004.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000004 |
| 2025-02-03 | 12:05 ET | [8-K](/filings/0001689375-25-000002.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001689375-25-000002 |
| 2025-01-15 | 21:05 ET | [8-K](/filings/0001104659-25-003755.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-003755 |
| 2024-11-05 | 12:12 ET | [10-Q](/filings/0001689375-24-000063.md) | Quarterly report, period 2024-09-30 | 0001689375-24-000063 |
| 2024-11-05 | 12:06 ET | [8-K](/filings/0001689375-24-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000061 |
| 2024-08-13 | 11:14 ET | [10-Q](/filings/0001689375-24-000047.md) | Quarterly report, period 2024-06-30 | 0001689375-24-000047 |
| 2024-08-13 | 11:05 ET | [8-K](/filings/0001689375-24-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000045 |
| 2024-06-26 | 20:54 ET | [SC 13D/A](/filings/0001104659-24-075206.md) | Ownership report, active investor, amended | 0001104659-24-075206 |
| 2024-06-24 | 11:25 ET | [8-K](/filings/0001104659-24-074130.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-074130 |
| 2024-06-24 | 10:07 ET | [8-K](/filings/0001104659-24-074078.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-074078 |
| 2024-06-13 | 20:05 ET | [8-K](/filings/0001104659-24-071249.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-071249 |
| 2024-05-07 | 11:10 ET | [10-Q](/filings/0001689375-24-000027.md) | Quarterly report, period 2024-03-31 | 0001689375-24-000027 |
| 2024-05-07 | 11:04 ET | [8-K](/filings/0001689375-24-000025.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000025 |
| 2024-04-29 | 13:11 ET | [DEF 14A](/filings/0001104659-24-053564.md) | Proxy statement, period 2024-06-13 | 0001104659-24-053564 |
| 2024-03-13 | 11:24 ET | [10-K](/filings/0001689375-24-000016.md) | Annual report, period 2023-12-31 | 0001689375-24-000016 |
| 2024-03-13 | 11:08 ET | [8-K](/filings/0001689375-24-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-24-000014 |
| 2024-01-03 | 12:16 ET | [8-K](/filings/0001104659-24-000571.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-000571 |
| 2023-12-06 | 12:00 ET | [8-K](/filings/0001104659-23-123805.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-123805 |
| 2023-11-22 | 12:35 ET | [8-K](/filings/0001104659-23-120557.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-120557 |
| 2023-11-07 | 12:20 ET | [10-Q](/filings/0001689375-23-000074.md) | Quarterly report, period 2023-09-30 | 0001689375-23-000074 |
| 2023-11-07 | 12:08 ET | [8-K](/filings/0001689375-23-000072.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001689375-23-000072 |
| 2023-11-01 | 11:01 ET | [8-K](/filings/0001104659-23-113138.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-113138 |
| 2023-09-29 | 20:39 ET | [8-K](/filings/0001104659-23-105351.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-105351 |
| 2023-09-21 | 11:09 ET | [8-K](/filings/0001689375-23-000068.md) | 8.01 Other events | 0001689375-23-000068 |

Page 1 of 2. [Older](/companies/trda/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.